NCT03866304 is a NA clinical trial of Device: S2 Picosecond laser in Tattoo Removal, sponsored by LigthSense Israel Ltd.

Who is sponsoring NCT03866304?

NCT03866304 is sponsored by LigthSense Israel Ltd.

What drugs are being tested in NCT03866304?

Interventions in NCT03866304: Device: S2 Picosecond laser.

What condition does NCT03866304 study?

NCT03866304 studies Tattoo Removal.

Is NCT03866304 still recruiting?

NCT03866304 is currently status unknown. Last updated 7 March 2019.

Last reviewed 2019-03-07 · How we verify

NCT03866304

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Performance Evaluation of Tattoo Removal

Status unknown NA Last updated 7 March 2019

What this trial tests

NA trial testing Device: S2 Picosecond laser in Tattoo Removal in 60 participants. Status unknown.

Timeline

21 January 2019

Primary endpoint
31 August 2019

31 August 2019

Quick facts

Lead sponsor	LigthSense Israel Ltd
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	21 January 2019
Primary completion	31 August 2019
Estimated completion	31 August 2019
Sites	1 location across Lithuania

Drugs / interventions tested

Device: S2 Picosecond laser

Conditions studied

Tattoo Removal — all drugs for Tattoo Removal →

Sponsor

LigthSense Israel Ltd

Who can join

Adults 18 to 65, any sex, with Tattoo Removal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate safety and efficacy of S2 multi-wavelength laser for tattoo removal

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Tattoo Removal

Currently open trials in the same condition.

NCT06202274 — Clinical Study to Evaluate the Safety and Efficacy of Candela Technology · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03866304 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by LigthSense Israel Ltd
Last refreshed: 7 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03866304.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing